A new review of Pediatric Acute Respiratory Distress Syndrome (PARDS) highlights the lack of data available for standard treatment approaches and adjunctive
Nanoparticle diffusion in spontaneously expectorated sputum as a biophysical tool to probe disease severity in COPD
Conflict of interest: R. Wise reports grants and personal fees for data monitoring committee work and consultancy from AstraZeneca/Medimmune and GSK, grants and personal fees for data monitoring and steering committee work